Leonard Davis Institute of Health Economics, Saint Joseph's University, Philadelphia, PA, USA.
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania Health Systems, Philadelphia, PA, USA.
Support Care Cancer. 2024 Apr 29;32(5):317. doi: 10.1007/s00520-024-08514-2.
Transportation is an underrecognized, but modifiable barrier to accessing cancer care, especially for clinical trials. Clinicians, insurers, and health systems can screen patients for transportation needs and link them to transportation. Direct transportation services (i.e., ride-sharing, insurance-provided transportation) have high rates of patient satisfaction and visit completion. Patient financial reimbursements provide necessary funds to counteract the effects of transportation barriers, which can lead to higher trial enrollment, especially for low socioeconomic status and racially and ethnically diverse patients. Expanding transportation interventions to more cancer patients, and addressing knowledge, service, and system gaps, can help more patients access needed cancer care.
交通是获得癌症治疗，特别是临床试验的一个被低估但可改变的障碍。临床医生、保险公司和医疗系统可以为患者的交通需求进行筛查，并为其提供交通服务。直接交通服务（即拼车、保险公司提供的交通）有很高的患者满意度和就诊完成率。患者的财务报销提供了必要的资金来抵消交通障碍的影响，这可以导致更高的试验入组率，特别是对于低社会经济地位和种族和族裔多样化的患者。扩大交通干预措施以惠及更多癌症患者，并解决知识、服务和系统差距，可以帮助更多患者获得所需的癌症治疗。
